Literature DB >> 10214987

Differential expression of the parkin gene in the human brain and peripheral leukocytes.

Y Sunada1, F Saito, K Matsumura, T Shimizu.   

Abstract

Molecular cloning of the responsible gene on chromosome 6q25.2-27 for autosomal recessive juvenile parkinsonism (AR-JP) identified a novel protein of unknown function, named parkin. In patients with AR-JP, deletions most commonly involve exons 3-5 in the parkin gene. For mutation screening we tried to analyze the parkin transcript amplified by RT-PCR. Based on the assumption that illegitimate transcription of the parkin gene may occur in every cell type, we successfully amplified the parkin message from human peripheral leukocytes using RT-PCR. The parkin transcript in leukocytes was smaller in size than the full-length transcript in the brain. DNA sequencing determined that exons 3-5 were spliced out in the normal human leukocyte transcript. Our results demonstrate that alternative splicing produces distinct parkin transcripts in different tissues. Moreover, physiological splicing of deletion-prone exons may provide an important clue to understanding the pathogenesis of AR-JP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10214987     DOI: 10.1016/s0304-3940(98)00697-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Parkin transcript variants in rat and human brain.

Authors:  Velia Dagata; Sebastiano Cavallaro
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

2.  Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.

Authors:  E K Tan; H Shen; J M M Tan; K L Lim; S Fook-Chong; W P Hu; M C Paterson; V R Chandran; K Yew; C Tan; Y Yuen; R Pavanni; M C Wong; K Puvan; Y Zhao
Journal:  Neurogenetics       Date:  2005-08-06       Impact factor: 2.660

3.  Molecular markers of early Parkinson's disease based on gene expression in blood.

Authors:  Clemens R Scherzer; Aron C Eklund; Lee J Morse; Zhixiang Liao; Joseph J Locascio; Daniel Fefer; Michael A Schwarzschild; Michael G Schlossmacher; Michael A Hauser; Jeffery M Vance; Lewis R Sudarsky; David G Standaert; John H Growdon; Roderick V Jensen; Steven R Gullans
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

4.  Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA.

Authors:  Adriana Malena; Boris Pantic; Doriana Borgia; Gianluca Sgarbi; Giancarlo Solaini; Ian J Holt; Antonella Spinazzola; Egle Perissinotto; Marco Sandri; Alessandra Baracca; Lodovica Vergani
Journal:  Autophagy       Date:  2016-09-14       Impact factor: 16.016

5.  Loss of locus coeruleus neurons and reduced startle in parkin null mice.

Authors:  Rainer Von Coelln; Bobby Thomas; Joseph M Savitt; Kah Leong Lim; Masayuki Sasaki; Ellen J Hess; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

6.  Parkin expression profile in dopamine d3 receptor knock-out mice brains.

Authors:  Velia D'Agata; Adriana Tiralongo; Alessandro Castorina; Gian Marco Leggio; Vincenzo Micale; Maria Luisa Carnazza; Filippo Drago
Journal:  Neurochem Res       Date:  2008-07-09       Impact factor: 3.996

Review 7.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

8.  Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene.

Authors:  Valentina La Cognata; Rosario Iemmolo; Velia D'Agata; Soraya Scuderi; Filippo Drago; Mario Zappia; Sebastiano Cavallaro
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

9.  Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

Authors:  Judith A Potashkin; Jose A Santiago; Bernard M Ravina; Arthur Watts; Alexey A Leontovich
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

10.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.